Eiko Lifesciences Acquires 25.01% Stake in Reflux Pharmaceuticals for INR 7 Crore

Eiko Lifesciences Limited has completed the acquisition of a 25.01% stake in Reflux Pharmaceuticals Private Limited for a consideration of INR 7.008 crore. As a result, Reflux Pharmaceuticals has become an associate company of Eiko Lifesciences. Reflux Pharmaceuticals is a private limited company involved in manufacturing and marketing of Active Pharmaceutical ingredients and Intermediates. The acquisition will benefit Eiko Lifesciences in its long-term strategic growth plan to diversify its portfolio by setting its footprints in various Geographic areas and will make Eiko Lifesciences the preferred source of supply for some key raw materials for Reflux Pharmaceuticals.